Amendment S-5124 to HF 2668
Relating to insurance coverage for biomarker testing
Adopted · April 9, 2024
Filed April 8, 2024 in the Senate by Sen. Waylon Brown (R)
What it changes
- Page 1, by striking lines 14 through 17 and inserting: “c. “Clinical utility” means sufficient medical and scientific evidence indicating that the use of a biomarker test will provide meaningful information that affects treatment decisions and guides improvement of net health outcomes, including an improved quality of life or longer survival.”